Annual Shareholders Equity
$11.07 M
-$88.92 M-88.92%
December 1, 2023
Summary
- As of March 13, 2025, ZVSA annual stockholders equity is $11.07 million, with the most recent change of -$88.92 million (-88.92%) on December 1, 2023.
- During the last 3 years, ZVSA annual shareholders equity has risen by +$19.63 million (+229.41%).
- ZVSA annual shareholders equity is now -88.92% below its all-time high of $99.99 million, reached on December 31, 2022.
Performance
ZVSA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$7.03 M
-$1.59 M-18.48%
September 1, 2024
Summary
- As of March 13, 2025, ZVSA quarterly stockholders equity is $7.03 million, with the most recent change of -$1.59 million (-18.48%) on September 1, 2024.
- Over the past year, ZVSA quarterly shareholders equity has dropped by -$4.20 million (-37.39%).
- ZVSA quarterly shareholders equity is now -92.97% below its all-time high of $99.99 million, reached on December 31, 2022.
Performance
ZVSA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ZVSA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -88.9% | -37.4% |
| 3 y3 years | +229.4% | +146.2% |
| 5 y5 years | +229.4% | +146.2% |
ZVSA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.9% | +188.6% | -93.0% | +146.2% |
| 5 y | 5-year | -88.9% | +188.6% | -93.0% | +146.2% |
| alltime | all time | -88.9% | +188.6% | -93.0% | +146.2% |
ZyVersa Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.03 M(-18.5%) |
| Jun 2024 | - | $8.62 M(-23.2%) |
| Mar 2024 | - | $11.22 M(+1.3%) |
| Dec 2023 | $11.07 M | $11.07 M(-43.8%) |
| Sep 2023 | - | $19.70 M(-1.8%) |
| Jun 2023 | - | $20.06 M(-79.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $97.10 M(-2.9%) |
| Dec 2022 | $99.99 M(-899.9%) | $99.99 M(-947.2%) |
| Sep 2022 | - | -$11.80 M(-22.5%) |
| Jun 2022 | - | -$15.22 M(+21.8%) |
| Dec 2021 | -$12.50 M(+46.1%) | - |
| Dec 2021 | - | -$12.50 M |
| Dec 2020 | -$8.56 M | - |
FAQ
- What is ZyVersa Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual shareholders equity year-on-year change?
- What is ZyVersa Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly shareholders equity year-on-year change?
What is ZyVersa Therapeutics annual stockholders equity?
The current annual shareholders equity of ZVSA is $11.07 M
What is the all time high annual shareholders equity for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual stockholders equity is $99.99 M
What is ZyVersa Therapeutics annual shareholders equity year-on-year change?
Over the past year, ZVSA annual stockholders equity has changed by -$88.92 M (-88.92%)
What is ZyVersa Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ZVSA is $7.03 M
What is the all time high quarterly shareholders equity for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly stockholders equity is $99.99 M
What is ZyVersa Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ZVSA quarterly stockholders equity has changed by -$4.20 M (-37.39%)